Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07518888 · ClinicalTrials.gov registry record · NA
Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer
A NA study, sponsored by University of Miami.
- Not yet
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT07518888: Clinical Trial NA study, sponsored by University of Miami.
NCT07518888 is a NA study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07518888, a NA study, has not yet begun recruiting, sponsored by University of Miami.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this research study is to understand how a short session of a home-based bodyweight high-intensity interval training (HIIT) affects steroid hormone levels in men on active surveillance for low-grade prostate cancer.
Primary Outcome
Protocol Completion Rate is defined as the proportion of enrolled participants who complete both the supervised home-based HIIT exercise session and return all scheduled saliva samples to the laboratory.
Interventions
- BEHAVIORAL High-Intensity Interval Training (HIIT) Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2026-05 |
| Est. Completion | 2027-03 |
| Phase | NA |
What is known before NCT07518888 opens enrollment
NCT07518888 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which High-Intensity Interval Training (HIIT) Exercise is the first listed.
NCT07518888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07518888 about?
NCT07518888 is a clinical study titled "Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer". The purpose of this research study is to understand how a short session of a home-based bodyweight high-intensity interval training (HIIT) affects steroid hormone levels in men on active surveillance for low-grade prostate cancer.
What is the current status of trial NCT07518888?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 49 participants. The study started on 2026-05. Estimated completion is 2027-03.
What interventions are being tested in trial NCT07518888?
The interventions under investigation include: High-Intensity Interval Training (HIIT) Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT07518888?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07518888's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia